Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Insite, MyCare Psychiatry, PERSERIS, Trinomia and Vascepa. Its lead product is Clozaril, which is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Trinomia product related to the treatment of cardiovascular disease.


TSX:HLS - Post by User

Bullboard Posts
Comment by TimeScapeon Feb 10, 2013 2:44am
246 Views
Post# 20964417

RE: RE: RE: AM Attracting Analyst Attention

RE: RE: RE: AM Attracting Analyst Attention

GuruInvesting - perhaps you are unfamiliar with Marketcall, but the analyst is always required to state whether he holds a stock or not.  Donville's comment about AM was that he was currently investigating it, and so far it looked good, but he hadn't purchased it yet.  He made a similar comment about Rifco a few weeks back, and then this time, he stated he had purchased that security, and he named it as a top pick.  If you follow Donville's comments from interview to interview, you will realize that he is extremely consistent in explaining what he currently owns, why he owns it, and when he sells something and why he sold it. 

I have absolutely no worries about Donville's honesty.  I've been following his picks for over 2 years now, and have done extremely well by picking up the stocks he recommends.  Actually, a lot of his recommendations have been remarkably consistent for well over 2 years - he has consistently recommended Home Capital, Paladin Labs, Constellation Software, Carfinco, Argonaut Gold and others.  There have been a few that he has soured on, and he explained why, such as Wi-Lan.  The guy has an amazing ability to pick stocks that go up consistently over the long run.

Bullboard Posts